Clinical spectrum and therapeutic approach to hepatocellular injury in patients with hyperthyroidism

Clinical and Experimental Gastroenterology

Volumn 6, Issue 1, 2013, Pages 9-17

  Mazo, Daniel Ferraz de Campos ^a   de Vasconcelos, Graciana Bandeira Salgado ^a   Pereira, Maria Adelaide Albergaria ^a   de Mello, Evandro Sobroza ^a   Bacchella, Telesforo ^a   Carrilho, Flair Jose ^a   Cançado, Eduardo Luiz Rachid ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Autoimmune hepatitis; Drug induced hepatitis; Liver function tests; Thyroid disease; Thyrotoxicosis hepatitis

Indexed keywords

AMINOTRANSFERASE; AMPHOTERICIN; AZATHIOPRINE; CAPTOPRIL; CEFTAZIDIME; CORTICOSTEROID; DIGITALIS; DIURETIC AGENT; HYDROCORTISONE; IMIPENEM; INSULIN; IODINE; LITHIUM CARBONATE; PREDNISONE; PROPRANOLOL; PROPYLTHIOURACIL; RADIOACTIVE IODINE; THIAMAZOLE; VANCOMYCIN;

ABDOMINAL DISTENSION; ABDOMINAL PAIN; ACUTE LIVER FAILURE; ADOLESCENT; ADULT; AMINOTRANSFERASE BLOOD LEVEL; ANIMAL TISSUE; ANOREXIA; ARTHRALGIA; ARTICLE; ASCITES; AUSCULTATION; AUTOIMMUNE HEPATITIS; BLOOD CLOTTING DISORDER; CASE REPORT; CONGESTIVE HEART FAILURE; CONSCIOUSNESS DISORDER; DEHYDRATION; DIABETES MELLITUS; DIARRHEA; DISEASE ASSOCIATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSPNEA; EPILEPTIC STATE; EXOPHTHALMOS; FEMALE; FEVER; GASTROINTESTINAL HEMORRHAGE; GOITER; GRAVES DISEASE; HEART FAILURE; HEPATIC ENCEPHALOPATHY; HEPATOMEGALY; HISTOPATHOLOGY; HUMAN; HYPERBILIRUBINEMIA; HYPERTHYROIDISM; HYPOKALEMIA; JAUNDICE; KIDNEY TUBULE ACIDOSIS; LEUKOPENIA; LIVER BIOPSY; LIVER CELL DAMAGE; LIVER CIRRHOSIS; LIVER FAILURE; LIVER TOXICITY; LIVER TRANSPLANTATION; MALAISE; METABOLIC ACIDOSIS; MULTIPLE ORGAN FAILURE; NAUSEA; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGURIA; PERIPHERAL EDEMA; PHYSICAL EXAMINATION; PLEURA EFFUSION; PRURITUS; SYSTOLIC HEART MURMUR; TACHYCARDIA; THORAX RADIOGRAPHY; THROMBOCYTOPENIA; THYROID CRISIS; THYROIDECTOMY; THYROTOXICOSIS; TREMOR; URINARY TRACT INFECTION; URTICARIA; VOMITING; WEAKNESS; WEIGHT REDUCTION;

EID: 84874314709     PISSN: None     EISSN: 11787023     Source Type: Journal    
DOI: 10.2147/CEG.S39358     Document Type: Article

References (34)

1. Khemichian S, Fong TL. Hepatic dysfunction in hyperthyroidism. Gastroenterol Hepatol (N Y). 2011;7:337-339.
2. Youssef WI, Mullen KD. The liver in other (nondiabetic) endocrine disorders. Clin Liver Dis. 2002;6:879-889.
3. Kubota S, Amino N, Matsumoto Y, etal. Serial changes in liver function tests in patients with thyrotoxicosis induced by Graves' disease and painless thyroiditis. Thyroid. 2008;18:283-287.
4. Babb RR. Associations between diseases of the thyroid and the liver. Am J Gastroenterol. 1984;79:421-423.
5. Fong TL, McHutchinson JG, Reynolds TB. Hyperthyroidism and hepatic dysfunction. A case series analysis. J Clin Gastroenterol. 1992;14:240-244.
6. Huang MJ, Li KL, Wei JS, Wu SS, Fan KD, Liaw YF. Sequential liver and bone biochemical changes in hyperthyroidism: prospective controlled follow-up study. Am J Gastroenterol. 1994;89:1071-1076.
7. Hull K, Horenstein R, Naglieri R, Munir K, Ghany M, Celi FS. Two cases of thyroid storm-associated cholestatic jaundice. Endocr Pract. 2007;13:476-480.
8. Choudhary AM, Roberts I. Thyroid storm presenting with liver failure. J Clin Gastroenterol. 1999;29:318-321.
9. Bellassoued M, Mnif M, Kaffel N, etal. Thyrotoxicosis hepatitis: a case report. Ann Endocrinol (Paris). 2001;62:235-238.
10. Barzilay-Yoseph L, Shabun A, Shilo L, Hadary R, Nabriski D, Kitay-Cohen Y. Thyrotoxic hepatitis. Isr Med Assoc J. 2011;13: 448-450.
11. Bénichou C. Criteria of drug-induced liver disorders. Report of an international consensus meeting. J Hepatol. 1990;11:272-276.
12. Dolman KM, Gans RO, Vervaat TJ, etal. Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy. Lancet. 1993;342:651-652.
13. Vogt BA, Kim Y, Jennette JC, Falk RJ, Burke BA, Sinaiko A. Antineutrophil cytoplasmic autoantibody-positive crescentic glomerulonephritis as a complication of treatment with propylthiouracil in children. J Pediatr. 1994;124:986-988.
14. Maggiore G, Larizza D, Lorini R, De Giacomo C, Scotta MS, Severi F. Propylthiouracil hepatotoxicity mimicking autoimmune chronic active hepatitis in a girl. J Pediatr Gastroenterol Nutr. 1989;8:547-548.
15. Alvarez F, Berg PA, Bianchi FB, etal. International Autoimmune Hepatitis Group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999;31:929-938.
16. Farias AQ. Acidose tubular renal distal nas doenças hepáticas: análise dos fatores de risco (tese). São Paulo, Brazil: Faculdade de Medicina; 2001. Portuguese.
17. Burch HB, Wartofsky L. Life-threatening thyrotoxicosis. Thyroid storm. Endocrinol Metab Clin North Am. 1993;22:263-277.
18. Kay PS, Keefe EB. Cardiac disease. In: Gitlin N, editor. The Liver and Systemic Diseases. New York, NY: Churchill Livingston; 1997.
19. Kandil E, Khalek MA, Thethi T, Abd Elmageed Z, Khan A, Jaffe BM. Thyroid storm in a patient with fulminant hepatic failure. Laryngoscope. 2011;121:164-166.
20. Ezer A, Caliskan K, Parlakgumus A, Belli S, Kozanoglu I, Yildirim S. Preoperative therapeutic plasma exchange in patients with thyrotoxicosis. J Clin Apher. 2009;24:111-114.
21. Myers JD, Brannon ES, Holland BC. A correlative study of the cardiac output and the hepatic circulation in hyperthyroidism. J Clin Invest. 1950;29:1069-1077.
22. Shimizu Y. Liver in systemic disease. World J Gastroenterol. 2008;14: 4111-4119.
23. Jansen PL, Froeling PG, Schade RW, Kloppenborg PW, Yap SH, Van Haelst UJ. Intrahepatic cholestasis in hyperthyroidism and the effect of antithyroid and beta-blocking drugs. Neth J Med. 1982;25: 318-324.
24. Goglia F, Liverini G, Lanni A, Barletta A. Mitochondrial DNA, RNA and protein synthesis in normal, hypothyroid and mildly hyperthyroid rat liver during cold exposure. Mol Cell Endocrinol. 1988;55:141-147.
25. Carithers RL. Endocrinologic disease. In: Gitlin N, editor. The Liver and Systemic Diseases. New York, NY: Churchill Livingston; 1997.
26. Cooper DS. Treatment of thyrotoxicosis. In: Braverman LE, Utiger RD, editors. Werner and Ingbar's The Thyroid, 7th ed. Philadelphia, PA: Lippincott-Raven; 2004.
27. Cooper DS. Antithyroid drugs. N Engl J Med. 2005;352:905-917.
28. Solá Izquierdo E, Morillas Ariño C, Peña Guillermo H, Muñoz Ferrer ML, Morillas Ariño J, Hernández Mijares A. Hepatitis colestásica por metimazol. Endocrinol Nutr. 2002;49:127-129. Spanish.
29. Liaw YF, Huang MJ, Fan KD, Li KL, Wu SS, Chen TJ. Hepatic injury during propylthiouracil therapy in patients with hyperthyroidism. A cohort study. Ann Intern Med. 1993;118:424-428.
30. Majeed M, Babu A. Cholestasis secondary to hyperthyroidism made worse by methimazole. Am J Med Sci. 2006;332:51-53.
31. Aydemir S, Bayraktaroglu T, Demircan N, etal. Effect of hyperthyroidism and propylthiouracil treatment on liver biochemical tests. Int J Clin Pract. 2005;59:1304-1308.
32. Casallo Blanco S, Valero MA, Marcos Sanchez F, de Matias Salces L, Blanco Gonzalez JJ, Martin Barranco MJ. Methimazole and propylthiouracil induced acute toxic hepatitis. Gastroenterol Hepatol. 2007;30: 268-270.
33. Nagai T, Imamura M, Kamiya Y, Mori M. Graves' disease accompanied by anti-myeloperoxidade antibody-related nephropathy and autoimmune hepatitis. Intern Med. 2004;43:516-520.
34. Nobili V, Liaskos C, Luigi G, Guidi R, Francalanci P, Marcellini M. Autoimmune thyroiditis associated with autoimmune hepatitis. Thyroid. 2005;5:1193-1195.